Dr. Leonard On Ibrutinib Combined With Chemotherapy In Follicular Lymphoma

Dr. Leonard on Ibrutinib Combined With Chemotherapy in Follicular Lymphoma

Smart Start for newly diagnosed DLBCL: rituximab/lenalidomide/ibrutinib

VJHemOnc – Video Journal of Hematology & HemOnc

Dr. John Leonard on Treatment Options for Relapsed Follicular Lymphoma

Dr. John Leonard on Treatment Options in Follicular Lymphoma

Targeted Oncology

Dr. Leonard on Treatment Options for Patients With Indolent B-Cell NHL

Combining Targeted and Immunotherapeutic Agents in Follicular Lymphoma

Dr. Leonard on Treating Relapsed Patients With Follicular Lymphoma

Ibrutinib in combination with rituximab – the future of treating FL

VJHemOnc – Video Journal of Hematology & HemOnc

Dr. Leonard on Lenalidomide With Rituximab in Follicular Lymphoma

Follicular Lymphoma: Combination Approaches

The Role of Ibrutinib in Follicular Lymphoma

Dr. John Leonard on When to Treat Patients With Follicular Lymphoma

Targeted Oncology

Dr. Leonard on Emergence of CAR T-cell Therapy in Hematologic Cancers

A Phase II single-arm study of obinutuzumab plus ibrutinib as frontline treatment for FL and MZL

VJHemOnc – Video Journal of Hematology & HemOnc

Intratumoral CpG, ibrutinib and radiotherapy in low-grade R/R follicular lymphoma

VJHemOnc – Video Journal of Hematology & HemOnc

Chemotherapy-Free Induction with Ibrutinib-Rituximab

Cancer Therapy Advisor

Dr. Leonard on Rituximab Maintenance Strategy for Patients With MCL

Dr John P Leonard Live Q&A Living with Follicular Lymphoma

Nicky Greenhalgh

Dr. Batlevi on Safety With Ibrutinib/Buparlisib in MCL, FL, and DLBCL

Ibrutinib, rituximab and venetoclax in the treatment of patients with newly diagnosed MCL

VJHemOnc – Video Journal of Hematology & HemOnc